3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Genitourinary
1
Dermatologic
1
Conditions
Prostatic Neoplasms
46
Kidney Neoplasms
11
Carcinoma, Renal Cell
11
Urinary Bladder Neoplasms
9
Neoplastic Cells, Circulating
8
Neoplasms
8
Breast Neoplasms
7
Neoplasm Metastasis
5
Melanoma
5
Sarcoma
4
Carcinoma, Non-Small-Cell Lung
4
Testicular Neoplasms
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Disease
3
Colorectal Neoplasms
3
von Hippel-Lindau Disease
2
Wilms Tumor
2
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Prostatic Hyperplasia
2
Pancreatic Neoplasms
2
Neuroblastoma
2
Liver Neoplasms
2
Leukemia
2
Kidney Diseases
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Clear-cell metastatic renal cell carcinoma
2
Interventions
Trastuzumab
2
Everolimus
2
vatalanib
1
tipifarnib
1
pentetreotide
1
Sunitinib
1
Specimen Handling
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Interleukin-12 Subunit p35
1
Interleukin-12
1
High-Energy Shock Waves
1
Fentanyl
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Somatostatinoma
×
Blood Specimen Collection
×
Genitourinary
×
Clear all
NCT01528774
2017-07-26
CTC
Comprehensive Cancer Centers of Nevada
Completed
150 enrolled